Psoriasis Drugs Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 – 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC851

Introduction

Psoriasis is a long-lasting disease which forms patches at skin surface. It involves rapid development of cells which produce silver scales, thick, and make the skin, flaky, red, dry and itchy. Various types of psoriasis are guttate, vulgaris, pustular, inverse, erythrodermic, palmoplantar, nail, and scalp psoriasis. In addition, approximately 10%-12% among the populations has severe diagnosis and suffers from different forms of psoriasis and 85%-90% of the people fall under major to minor category of psoriasis. At present, long-lasting cure is not available for this syndrome. However in order to halt the growth of cells on the surface of the skin, preventative measures can be adopted. Psoriasis can be treated either with biopharmaceuticals or pharmaceuticals therapies through systemic and topical process. These medications when directed, either consumed orally, or by applying on the skin,  or through inoculations, specifically block parts of immune system process by targeting phosphodiesterase type 4, tumour necrosis factor, and interleukin among others.

Market Dynamics

Availability of better and advanced diagnostic devices results in constructing assurance in people, thereby resulting in adoption of treatment. Rising healthcare expenditure is also stimulating market growth. Due to the high cost in drug development, increasing availability of various generic products, side effects from the biologics and systemic medication such as liver and kidney damage, high blood pressure, infection, and cancer of the lymph nodes, also health insurance issues, low efficacy of the product and lack of access to healthcare may impede market growth. Increasing demand of psoriasis medicines in emerging economies, development of long-lasting drugs is expected to boost psoriasis market in forthcoming years.

Market Classification and Overview

The market can be bifurcated on the basis of therapeutic class, drugs, and geography. By therapeutic class, psoriasis drugs market can be segmented into tumor necrosis factor inhibitor, interleukin inhibitors, and vitamin-D analogues. Further tumor necrosis factor inhibitor is sub-classified into adalimumab, etanercept, infliximab. Also, interleukin inhibitors are sub-segmented into ustekinumab, secukinumab, ixekizumab, brodalumab. Vitamin-D analogues are further basified into calcitriol, calcipotriol, tacalcitol, and among others. By drugs, psoriasis drugs market can be segmented into topicals, systemic, and biologics. Topicals further segmented into over-the-counter (OTC) topicals, topical non-steroids, topical steroids.Systemic further sub-segmented into retinoid, cyclosporine, and methotrexate. Biologics sub- classified into tumor necrosis factor (TNF) inhibitors, interleukin 12 and 23 (IL-12/23) inhibitors, interleukin 17 (IL-17) inhibitors, and T-cell inhibitors. On the basis of geography, the psoriasis drugs market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

 

Report Coverage

Market

Psoriasis Drugs Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Therapeutic Class, Drugs, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major players involved in the supply of psoriasis drugs market include Johnson & Johnson, Novartis International AG, Pfizer Inc, Merck and Co. Inc, Celgene Corporation, Janssen Biotech Inc, Stiefel Laboratories Inc, Takeda Pharmaceutical Company Limited, Amgen Inc., and AbbVie among others.

Market Segmentation

Market By Therapeutic Class

  • Tumor Necrosis Factor Inhibitor

Adalimumab

Etanercept

Infliximab

  • Interleukin Inhibitors

Ustekinumab

Secukinumab

Ixekizumab

Brodalumab

  • Vitamin-D Analogues

Calcitriol

Calcipotriol

Tacalcitol

Others

Market By Drugs

  • Topicals

Over-the-counter (OTC) topicals

Topical non-steroids

Topical steroids

  • Systemic

Retinoid

Cyclosporine

Methotrexate

  • Biologics

Tumor Necrosis Factor (TNF) Inhibitors

Interleukin 12 and 23 (IL-12/23) Inhibitors

Interleukin 17 (IL-17) Inhibitors

T-cell Inhibitors

Market By Geography

North America

  • U.S.
  • Canada
  • Mexico

Europe

  • UK
  • France
  • Germany
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Chile
  • Rest of LATAM

Middle East and Africa (MEA)

  • South Africa
  • Saudi Arabia
  • Rest of MEA

 


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary